DataMeds AI, Inc.
- MEDS ยท Nasdaq
- Wholesale-Drugs, Proprietaries & Druggists' Sundries
- Tampa, FL
- CIK 0002030763
Updated from SEC filings through
Top things to know
Executives
- Prashant Patel Chief Executive Officer 4, 2026-06-25
- Eric Sherb Chief Financial Officer (Principal Financial Officer) 10-Q, 2026-08-17
What leadership is saying
“Having been in leadership now for just under three months, I am excited with the significant progress we are making towards the important milestone of launching the Health Lives Here app together with NFLAH”
Earnings press release (8-K Ex. 99.1), filed August 18, 2026
DataMeds AI, Inc. is a U.S. public company in wholesale-drugs, proprietaries & druggists' sundries (SIC 5122), headquartered in Tampa, FL. It trades as MEDS on Nasdaq. Revenue was $23.3M in the fiscal year ending December 31, 2025, +28.7% from the year before. Prashant Patel is Chief Executive Officer.
Five-year financials
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | $23.3M 10-K, 2026-03-20 | $18.1M 10-K, 2026-03-20 | Not on file |
| Operating income | -$93.7M 10-K, 2026-03-20 | -$6.1M 10-K, 2026-03-20 | -$2.9M 10-K, 2025-03-25 |
| SG&A | $71.6M 10-K, 2026-03-20 | $6.8M 10-K, 2026-03-20 | $2.9M 10-K, 2025-03-25 |
| Net income | -$101M 10-K, 2026-03-20 | -$6.9M 10-K, 2026-03-20 | -$2.9M 10-K, 2025-03-25 |
Annual figures from XBRL in each company's own filings. Click a figure to open the filing. SG&A marked derived is general and administrative plus selling and marketing.
Leadership and board
| Name | Title | Source |
|---|---|---|
| Prashant Patel | Chief Executive Officer | 4, 2026-06-25 |
| Eric Sherb | Chief Financial Officer (Principal Financial Officer) | 10-Q, 2026-08-17 |
| Michael L. Peterson | Director | 10-K, 2026-03-20 |
Shares and governance
| Shares outstanding | 3.1 million (as of August 17, 2026) | 10-Q, August 17, 2026 |
|---|---|---|
| Public float | $27.1M (as of June 30, 2025) | 10-K/A, April 24, 2026 |
| Reportable segments | 1 (period ending March 31, 2026) | 10-Q, May 19, 2026 |
| Latest proxy statement | Meeting May 4, 2026 (filed May 4, 2026) | DEF 14A, May 4, 2026 |
| Auditor | Suri & Co., Chartered Accountants (Bengaluru, India) | Latest 10-K |
Recent 8-K events
- 8-K filed 2026-11-05
- Item 1.02 Termination of a material definitive agreement
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-10-26
- Item 1.01 Entry into a material definitive agreement
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-10-20
- Item 7.01 Regulation FD disclosure
- Item 8.01 Other events
- 8-K filed 2026-10-16
- Item 1.01 Entry into a material definitive agreement
- Item 3.01 Notice of delisting or failure to meet listing standards
- Item 3.02 Unregistered sales of equity securities
- 8-K filed 2026-10-13
- Item 8.01 Other events
- 8-K filed 2026-09-17
- Item 8.01 Other events
- 8-K filed 2026-09-16
- Item 1.01 Entry into a material definitive agreement
- Item 2.03 Creation of a direct financial obligation
- Item 3.02 Unregistered sales of equity securities
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-08-18
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-08-14
- Item 8.01 Other events
- 8-K filed 2026-08-04
- Item 1.01 Entry into a material definitive agreement
Frequently asked questions about DataMeds AI, Inc.
- What does DataMeds AI, Inc. do?
- DataMeds AI, Inc. is classified by the SEC as Wholesale-Drugs, Proprietaries & Druggists' Sundries (SIC 5122). It is based in Tampa, FL.
- What is DataMeds AI, Inc.'s revenue?
- $23.3M for the fiscal year ending December 31, 2025, from its 10-K filed March 20, 2026.
- Is DataMeds AI, Inc. profitable?
- DataMeds AI, Inc. reported net income of -$101M for the fiscal year ending December 31, 2025.
- Who is the CEO of DataMeds AI, Inc.?
- Prashant Patel, Chief Executive Officer, as named in a 4 filed June 25, 2026.
- Who is the CFO of DataMeds AI, Inc.?
- Eric Sherb, Chief Financial Officer (Principal Financial Officer), as named in a 10-Q filed August 17, 2026.
- Where is DataMeds AI, Inc. headquartered?
- Tampa, FL.
- What is DataMeds AI, Inc.'s stock ticker?
- MEDS on Nasdaq.
- What industry is DataMeds AI, Inc. in?
- Wholesale-Drugs, Proprietaries & Druggists' Sundries, SIC code 5122.
- What is DataMeds AI, Inc.'s website?
- wellgisticshealth.com. Investor relations: https://datamedsai.com/investors/.
- When does DataMeds AI, Inc. report earnings next?
- November 18, 2026. Source: pg_future_events.
- Is DataMeds AI, Inc. a public company?
- Yes. DataMeds AI, Inc. files with the SEC under CIK 0002030763 and trades as MEDS.
- Who audits DataMeds AI, Inc.?
- Suri & Co., Chartered Accountants, Bengaluru, India, as named in its latest annual report (10-K).
- How many shares of DataMeds AI, Inc. are outstanding?
- 3.1 million shares as of August 17, 2026, from its 10-Q filed August 17, 2026.
- What is DataMeds AI, Inc.'s public float?
- $27.1M as of June 30, 2025, as reported on the cover of its 10-K/A filed April 24, 2026.
- How many business segments does DataMeds AI, Inc. report?
- 1 reportable segment for the period ending March 31, 2026, from its 10-Q filed May 19, 2026.
- When is DataMeds AI, Inc.'s annual shareholder meeting?
- May 4, 2026, per its proxy statement (DEF 14A) filed May 4, 2026.